Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer

Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors, immunotherapy, and antibody-drug conjugates, while discussing how biomarker testing guides patient selection and treatment sequencing. Through interactive case discussions, participants will learn practical approaches to integrating current and emerging therapies into individualized care plans. The activity also emphasizes proactive adverse event monitoring and management strategies that help patients remain on effective biomarker-directed therapies while maintaining quality of life.